5% DEXTROSE INJECTION, USP

Dextrose by

Drug Labeling and Warnings

Dextrose by is a Prescription medication manufactured, distributed, or labeled by Baxter Healthcare Company, Baxter Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DEXTROSE- dextrose monohydrate injection, solution 
Baxter Healthcare Company

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

5% DEXTROSE INJECTION, USP

Health Care Provider Letter

DHCP Letter 1 of 17
DHCP Letter 2 of 17
DHCP Letter 3 of 17
DHCP Letter 4 of 17
DHCP Letter 5 of 17
DHCP Letter 6 of 17
DHCP Letter 7 of 17
DHCP Letter 8 of 17
DHCP Letter 9 of 17
DHCP Letter 10 of 17
DHCP Letter 11 of 17
DHCP Letter 12 of 17
DHCP Letter 13 of 17
DHCP Letter 14 of 17
DHCP Letter 15 of 17
DHCP Letter 16 of 17
DHCP Letter 17 of 17

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Container Label NDC: <a href=/NDC/0338-9830-01>0338-9830-01</a>

Container Label

JB0062 250 mL DIN 00060348

5% Dextrose Injection USP

Dextrose à 5% USP, Injectable

D5W

2D Barcode
(01)00809080000258

APPROX mOsmol/L – 252
pH 4.0

INTRAVENOUS FLUID AND NUTRI-
ENT REPLENISHIMENT / RECHARGE
LIQUIDIENNE ET NUTRIMENT PAR
INJECTION INTRAVEINEUSE

PER 100 mL DEXTROSE HYDROUS
USP – 5 g / WATER FOR INJECTION
USP – qs / pH MAY BE ADJUSTED
WITH SODIUM HYDROXIDE

PAR 100 mL DEXTROSE HYDRATE USP – 5 g / EAU POUR
INJECTION USP – qs / pH PEUT ETRE AJUSTE AVEC DE
L’HYDROXYDE DE SODIUM

CAUTIONS SINGLE USE / DISCARD UNUSED PORTION
/ SQUEEZE AND INSPECT BAG / SEE DIRECTIONS FOR
USE / MUST NOT BE USED IN SERIES CONNECTIONS /
DO NOT ADMINISTER SIMULTANEOUSLY WITH BLOOD /
STORE AT 15°C TO 25°C

ATTENTIONS USAGE UNIQUE / JETER PORTION INTUI-
LISEE / PRESSER ET INSPECTOR LE SAC / VOIR MODE
D’EMPLOI / NE DOIT PAS ETRE MONTE EN SERIE / NE PAS
ADMINISTRER SIMULTANEMENT AVEC LA SANG / GARDER
ENTRE 15°C ET 25°C

NONPYROGENIC / STERILE / APYROGENE

VIAFLEX® PVC CONTAINER / CONTENANT DE PVC

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No Latex Label

88-70-20-465

50

100

150

200

Container Label NDC: <a href=/NDC/0338-9588-01>0338-9588-01</a>

Container Label

JB0064 1000 mL DIN 00060348

5% Dextrose
Injection USP

Dextrose à 5%
USP, Injectable

D5W

APPROX mOsmol/L – 252 pH 4.0

INTRAVENOUS FLUID AND NUTRIENT REPLENISHIMENT /
RECHARGE LIQUIDIENNE ET NUTRIMENT PAR INJECTION
INTRAVEINEUSE

PER 100 mL DEXTROSE HYDROUS USP – 5 g / WATER FOR
INJECTION USP – qs / pH MAY BE ADJUSTED WITH SODIUM
HYDROXIDE

PAR 100 mL DEXTROSE HYDRATE USP – 5 g / EAU POUR
INJECTION USP – qs / pH PEUT ETRE AJUSTE AVEC DE
L’HYDROXYDE DE SODIUM

CAUTIONS SINGLE USE / DISCARD UNUSED PORTION
SQUEEZE AND INSPECT BAG / SEE DIRECTIONS FOR USE
MUST NOT BE USED IN SERIES CONNECTIONS / DO NOT
ADMINISTER SIMULTANEOUSLY WITH BLOOD / STORE AT
15°C TO 25°C

ATTENTIONS USAGE UNIQUE / JETER PORTION INTUILISEE
PRESSER ET INSPECTOR LE SAC / VOIR MODE D’EMPLOI NE
DOIT PAS ETRE MONTE EN SERIE / NE PAS ADMINISTRER
SIMULTANEMENT AVEC LA SANG / GARDER ENTRE 15°C
ET 25°C

NONPYROGENIC / STERILE / APYROGENE

VIAFLEX PVC CONTAINER / CONTENANT DE PVC

BAXTER AND VIAFLEX ARE TRADEMARKS OF BAXTER INTERNATIONAL INC
BAXTER ET VIAFLEX SONT DES MARQUES DE COMMERCE DE BAXTER
INTERNATIONAL INC

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No Latex Label

07-25-77-316

1

_

2

_

3

_

4

_

5

_

6

_

7

_

8

_

9

DEXTROSE 
dextrose monohydrate injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 0338-9830
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE50 g  in 1000 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 0338-9830-0330 in 1 CARTON11/06/202404/23/2025
1NDC: 0338-9830-01250 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage11/06/202404/23/2025
DEXTROSE 
dextrose monohydrate injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 0338-9588
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE50 g  in 1000 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 0338-9588-1212 in 1 CARTON11/06/202404/23/2025
1NDC: 0338-9588-011000 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage11/06/202404/23/2025
Labeler - Baxter Healthcare Company (005083209)
Establishment
NameAddressID/FEIBusiness Operations
Baxter Corporation205087968ANALYSIS(0338-9830, 0338-9588) , LABEL(0338-9830, 0338-9588) , MANUFACTURE(0338-9830, 0338-9588) , STERILIZE(0338-9830, 0338-9588) , PACK(0338-9830, 0338-9588)

Revised: 11/2024
Document Id: 358f08bc-8a80-421f-98c3-302382e5f2c5
Set id: 4f985a81-59e1-41b5-adcd-357391e79293
Version: 2
Effective Time: 20241106